BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31247322)

  • 1. Antifungal resistance in Aspergillus terreus: A current scenario.
    Vahedi Shahandashti R; Lass-Flörl C
    Fungal Genet Biol; 2019 Oct; 131():103247. PubMed ID: 31247322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus terreus: Novel lessons learned on amphotericin B resistance.
    Posch W; Blatzer M; Wilflingseder D; Lass-Flörl C
    Med Mycol; 2018 Apr; 56(suppl_1):73-82. PubMed ID: 29538736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insight into amphotericin B resistance in Aspergillus terreus.
    Blum G; Hörtnagl C; Jukic E; Erbeznik T; Pümpel T; Dietrich H; Nagl M; Speth C; Rambach G; Lass-Flörl C
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1583-8. PubMed ID: 23318794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
    Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
    J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains.
    Blatzer M; Blum G; Jukic E; Posch W; Gruber P; Nagl M; Binder U; Maurer E; Sarg B; Lindner H; Lass-Flörl C; Wilflingseder D
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3778-88. PubMed ID: 25870060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo role of heat shock protein 90 in Amphotericin B resistance of Aspergillus terreus.
    Blum G; Kainzner B; Grif K; Dietrich H; Zeiger B; Sonnweber T; Lass-Flörl C
    Clin Microbiol Infect; 2013 Jan; 19(1):50-55. PubMed ID: 22515428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential basis for amphotericin B resistance in Aspergillus terreus.
    Blum G; Perkhofer S; Haas H; Schrettl M; Würzner R; Dierich MP; Lass-Flörl C
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1553-5. PubMed ID: 18268082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphotericin B Resistance in Aspergillus terreus Is Overpowered by Coapplication of Pro-oxidants.
    Blatzer M; Jukic E; Posch W; Schöpf B; Binder U; Steger M; Blum G; Hackl H; Gnaiger E; Lass-Flörl C; Wilflingseder D
    Antioxid Redox Signal; 2015 Dec; 23(18):1424-38. PubMed ID: 26054424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis.
    Barchiesi F; Spreghini E; Sanguinetti M; Giannini D; Manso E; Castelli P; Girmenia C
    J Antimicrob Chemother; 2013 Nov; 68(11):2587-91. PubMed ID: 23794598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
    Lass-Flörl C; Griff K; Mayr A; Petzer A; Gastl G; Bonatti H; Freund M; Kropshofer G; Dierich MP; Nachbaur D
    Br J Haematol; 2005 Oct; 131(2):201-7. PubMed ID: 16197450
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Vahedi-Shahandashti R; Dietl AM; Binder U; Nagl M; Würzner R; Lass-Flörl C
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0227421. PubMed ID: 35254091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis.
    Ambati S; Ellis EC; Pham T; Lewis ZA; Lin X; Meagher RB
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.
    Hachem RY; Kontoyiannis DP; Boktour MR; Afif C; Cooksley C; Bodey GP; Chatzinikolaou I; Perego C; Kantarjian HM; Raad II
    Cancer; 2004 Oct; 101(7):1594-600. PubMed ID: 15378491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    Warn PA; Morrissey G; Morrissey J; Denning DW
    J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species.
    Fakhim H; Badali H; Dannaoui E; Nasirian M; Jahangiri F; Raei M; Vaseghi N; Ahmadikia K; Vaezi A
    J Mycol Med; 2022 Nov; 32(4):101310. PubMed ID: 35907396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies.
    Colozza C; Posteraro B; Santilli S; De Carolis E; Sanguinetti M; Girmenia C
    Int J Antimicrob Agents; 2012 May; 39(5):440-3. PubMed ID: 22429723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative Stress Response Tips the Balance in Aspergillus terreus Amphotericin B Resistance.
    Jukic E; Blatzer M; Posch W; Steger M; Binder U; Lass-Flörl C; Wilflingseder D
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.
    Lass-Flörl C; Kofler G; Kropshofer G; Hermans J; Kreczy A; Dierich MP; Niederwieser D
    J Antimicrob Chemother; 1998 Oct; 42(4):497-502. PubMed ID: 9818749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galleria mellonella as a host model to study Aspergillus terreus virulence and amphotericin B resistance.
    Maurer E; Browne N; Surlis C; Jukic E; Moser P; Kavanagh K; Lass-Flörl C; Binder U
    Virulence; 2015; 6(6):591-8. PubMed ID: 26107350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillusnidulans complex and Aspergillusterreus complex isolated from clinical specimens.
    Mohamadnia A; Salehi Z; Namvar Z; Tabarsi P; Pourabdollah-Toutkaboni M; Rezaie S; Marjani M; Moniri A; Abtahian Z; Mahdaviani SA; Mortezaee V; Askari E; Sharifynia S
    J Mycol Med; 2020 Sep; 30(3):101004. PubMed ID: 32534826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.